ArticleExperimental and therapeutic medicine2021

LGR6 promotes glioblastoma malignancy and chemoresistance by activating the Akt signaling pathway.

Yuan Yuan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.